Literature DB >> 19424028

Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters.

Ashleigh S Boyd1, Kathryn J Wood.   

Abstract

BACKGROUND: The progeny of embryonic stem (ES) cells may eventually be used to replace damaged tissues in transplantation, yet their immunogenicity remains ill-defined. The major histocompatibility complex (MHC) is a determinant of immunogenicity in transplantation. METHODS AND
RESULTS: Herein, we show differences in MHC expression between mouse ES cells and ES cell derived insulin producing cell clusters (IPCCs), including a relatively higher expression of MHC Class I in IPCCs and a faster, more dramatic induction of MHC Class I in IPCCs following challenge with interferon-gamma (IFN-gamma). MHC Class II was induced on IPCCs, but not ES cells, after exposure to IFN-gamma. Transplantation of syngeneic or allogeneic IPCCs was insufficient to trigger up-regulation of MHC class I within three days after transplantation. DISCUSSION: These data highlight differences in MHC expression between ES cells and a fully differentiated ES cell derived tissue and suggest how the progeny of ES cells may be susceptible to rejection after transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424028      PMCID: PMC2796795          DOI: 10.1097/TP.0b013e3181a19421

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

Review 1.  The human major histocompatability complex: lessons from the DNA sequence.

Authors:  S Beck; J Trowsdale
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

2.  Neural progenitor cells lack immunogenicity and resist destruction as allografts.

Authors:  Junko Hori; Tat Fong Ng; Marie Shatos; Henry Klassen; J Wayne Streilein; Michael J Young
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

Review 3.  Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation.

Authors:  Ashleigh S Boyd; Yasuyuki Higashi; Kathryn J Wood
Journal:  Adv Drug Deliv Rev       Date:  2005-11-11       Impact factor: 15.470

4.  Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients.

Authors:  Sabrina Bonde; Nicholas Zavazava
Journal:  Stem Cells       Date:  2006-06-22       Impact factor: 6.277

Review 5.  Indirect presentation of MHC antigens in transplantation.

Authors:  D A Shoskes; K J Wood
Journal:  Immunol Today       Date:  1994-01

6.  Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression.

Authors:  Joseph F Magliocca; Inka K A Held; Jon S Odorico
Journal:  Stem Cells Dev       Date:  2006-10       Impact factor: 3.272

7.  Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery.

Authors:  Jiwu Wei; Sabine Blum; Marcus Unger; Gergely Jarmy; Mathias Lamparter; Albert Geishauser; Georgios A Vlastos; Gordon Chan; Klaus-Dieter Fischer; Dirk Rattat; Klaus-Michael Debatin; Antonis K Hatzopoulos; Christian Beltinger
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

8.  Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets.

Authors:  E A Bach; S J Szabo; A S Dighe; A Ashkenazi; M Aguet; K M Murphy; R D Schreiber
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

9.  The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts.

Authors:  W N Peugh; R A Superina; K J Wood; P J Morris
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

10.  In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.

Authors:  Rutger-Jan Swijnenburg; Sonja Schrepfer; Feng Cao; Jeremy I Pearl; Xiaoyan Xie; Andrew J Connolly; Robert C Robbins; Joseph C Wu
Journal:  Stem Cells Dev       Date:  2008-12       Impact factor: 3.272

View more
  17 in total

Review 1.  Stem cell and gene therapies for diabetes mellitus.

Authors:  Roy Y Calne; Shu Uin Gan; Kok Onn Lee
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 2.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Authors:  Chad Tang; Micha Drukker
Journal:  Semin Immunopathol       Date:  2011-04-11       Impact factor: 9.623

Review 3.  In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages.

Authors:  Suzanne Kadereit; Alan Trounson
Journal:  Semin Immunopathol       Date:  2011-04-05       Impact factor: 9.623

Review 4.  Attenuated Innate Immunity in Embryonic Stem Cells and Its Implications in Developmental Biology and Regenerative Medicine.

Authors:  Yan-Lin Guo; Gordon G Carmichael; Ruoxing Wang; Xiaoxiao Hong; Dhiraj Acharya; Faqing Huang; Fengwei Bai
Journal:  Stem Cells       Date:  2015-07-06       Impact factor: 6.277

5.  Universal Surface Biotinylation: a simple, versatile and cost-effective sample multiplexing method for single-cell RNA-seq analysis.

Authors:  Michihiko Sugimoto; Yuhki Tada; Shigeyuki Shichino; Saeko Koyamatsu; Noriyuki Tsumaki; Kuniya Abe
Journal:  DNA Res       Date:  2022-05-27       Impact factor: 4.477

6.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

7.  Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters.

Authors:  Ashleigh S Boyd; Kathryn J Wood
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

Review 8.  Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives.

Authors:  Chad Tang; Irving L Weissman; Micha Drukker
Journal:  Methods Mol Biol       Date:  2013

9.  Generation of porcine induced pluripotent stem cells and evaluation of their major histocompatibility complex protein expression in vitro.

Authors:  Kyung-Mee Park; Sang-Ho Cha; Cheol Ahn; Heung-Myong Woo
Journal:  Vet Res Commun       Date:  2013-08-23       Impact factor: 2.459

Review 10.  Immunological barriers to stem-cell based cardiac repair.

Authors:  Zaruhi Karabekian; Nikki Gillum Posnack; Narine Sarvazyan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.